1. Induced Disease Models Products Others Metabolic Enzyme/Protease
  2. Immunology and Inflammatory Disease Models Environmental Pollutants Endogenous Metabolite
  3. Hapten
  4. trans-Cinnamaldehyde

trans-Cinnamaldehyde can be used to prepare highly polyfunctionalized furan ring by reaction of alkyl isocyanides with dialkyl acetylenedicarboxylate. trans-Cinnamaldehyde can be used to synthesize trans-cinnamaldehyde -β-cyclodextrin complex, an antimicrobial edible coating that increases the shelf life of fresh-cut fruits.

For research use only. We do not sell to patients.

CAS No. : 14371-10-9

Size Price Stock Quantity
1 g In-stock
5 g In-stock
10 g   Get quote  
50 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 7 publication(s) in Google Scholar

Other Forms of trans-Cinnamaldehyde:

Top Publications Citing Use of Products

    trans-Cinnamaldehyde purchased from MedChemExpress. Usage Cited in: Biomolecules. 2025 Feb 1;15(2):208.

    TRPA1 agonist cinnamaldehyde (CA, 5 mg/kg). In citric acid-induced enhanced cough guinea pigs, there was a significant increase in cough frequency. However, the cough frequency in the guinea pigs with a cough was not further increased by the activation of PAR2/TRPA1. Inhibition of PAR2 or TRPA1 significantly reduced the cough frequency in guinea pigs with a cough.

    trans-Cinnamaldehyde purchased from MedChemExpress. Usage Cited in: Biomolecules. 2025 Feb 1;15(2):208.

    TRPA1 agonist cinnamaldehyde (CA, 5 mg/kg). SP levels in the BALF of guinea pigs with a cough were further increased by the activation of PAR2. Inhibition of PAR2/TRPA1 decreased the level of SP in the BALF of guinea pigs with a cough.

    trans-Cinnamaldehyde purchased from MedChemExpress. Usage Cited in: Biomolecules. 2025 Feb 1;15(2):208.

    TRPA1 agonist cinnamaldehyde (CA, 5 mg/kg). The changes in CGRP levels in the BALF of guinea pigs.

    trans-Cinnamaldehyde purchased from MedChemExpress. Usage Cited in: Biomolecules. 2025 Feb 1;15(2):208.

    TRPA1 agonist cinnamaldehyde (CA, 5 mg/kg). The expression of TRPA1 in the nerve fibers of the trachea was increased in the citric acid-induced enhanced cough group after drug treatment. Activation of PAR2 upregulated TRPA1 expression, whereas inhibition of PAR2 in cough group suppressed TRPA1 expression.

    trans-Cinnamaldehyde purchased from MedChemExpress. Usage Cited in: Biomolecules. 2025 Feb 1;15(2):208.

    TRPA1 agonist cinnamaldehyde (CA, 5 mg/kg). The expression of PAR2 in the nerve fibers of the trachea was increased in the cough group after drug treatment, whereas TRPA1 receptor activation/inhibition had no effect on PAR2 expression.

    View All Endogenous Metabolite Isoform Specific Products:

    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    trans-Cinnamaldehyde can be used to prepare highly polyfunctionalized furan ring by reaction of alkyl isocyanides with dialkyl acetylenedicarboxylate[1]. trans-Cinnamaldehyde can be used to synthesize trans-cinnamaldehyde -β-cyclodextrin complex, an antimicrobial edible coating that increases the shelf life of fresh-cut fruits[2].

    Cellular Effect
    Cell Line Type Value Description References
    CHO EC50
    6.5 μM
    Compound: 15
    Activation of TRPA1 channel expressed in CHO cells assessed as increase in intracellular calcium levels
    Activation of TRPA1 channel expressed in CHO cells assessed as increase in intracellular calcium levels
    [PMID: 20356305]
    CHO EC50
    61 μM
    Compound: CA
    Agonist activity at mouse TRPA1 expressed in CHO cells assessed as increase in calcium influx by Fluo-3 based FLIPR analysis
    Agonist activity at mouse TRPA1 expressed in CHO cells assessed as increase in calcium influx by Fluo-3 based FLIPR analysis
    [PMID: 30878828]
    HCT-8 IC50
    15.6 μM
    Compound: 12; CA
    Antiproliferative activity against human HCT8 cells after 72 hrs in presence of aspirin by MTT assay
    Antiproliferative activity against human HCT8 cells after 72 hrs in presence of aspirin by MTT assay
    [PMID: 30037494]
    HCT-8 IC50
    29.4 μM
    Compound: 12; CA
    Antiproliferative activity against human HCT8 cells after 72 hrs by MTT assay
    Antiproliferative activity against human HCT8 cells after 72 hrs by MTT assay
    [PMID: 30037494]
    HEK293 EC50
    51.4 μM
    Compound: CA 3
    Agonist activity at human TRPA1 expressed in HEK293 cells assessed as [45]Ca2+ influx by microbeta plate count
    Agonist activity at human TRPA1 expressed in HEK293 cells assessed as [45]Ca2+ influx by microbeta plate count
    [PMID: 19945872]
    HEK293 EC50
    9 μM
    Compound: CA
    Agonist activity at human TRPA1 expressed in HEK293 cells assessed as increase in calcium influx by Fluo-4-AM dye based fluorescence assay
    Agonist activity at human TRPA1 expressed in HEK293 cells assessed as increase in calcium influx by Fluo-4-AM dye based fluorescence assay
    [PMID: 30878828]
    RAW264.7 IC50
    43 μM
    Compound: CA
    Inhibition of NF-kappaB transfected in LPS-stimulated mouse RAW264.7 cells
    Inhibition of NF-kappaB transfected in LPS-stimulated mouse RAW264.7 cells
    [PMID: 18823786]
    In Vitro

    trans-cinnamaldehyde -β-cyclodextrin complex against Salmonella spp. and Lis-teria spp. with minimum inhibitory concentrations ranging from 10 to 20 mg/mL, respectively[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Clinical Trial
    Molecular Weight

    132.16

    Formula

    C9H8O

    CAS No.
    Appearance

    Liquid (Density: 1.05 g/cm3)

    Color

    Colorless to light yellow

    SMILES

    O=C/C=C/C1=CC=CC=C1

    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage

    -20°C, stored under nitrogen

    *In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)

    Solvent & Solubility
    In Vitro: 

    DMSO : 50 mg/mL (378.33 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 7.5666 mL 37.8329 mL 75.6659 mL
    5 mM 1.5133 mL 7.5666 mL 15.1332 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.5 mg/mL (18.92 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 2.5 mg/mL (18.92 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

    *In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)

    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 99.41%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 7.5666 mL 37.8329 mL 75.6659 mL 189.1646 mL
    5 mM 1.5133 mL 7.5666 mL 15.1332 mL 37.8329 mL
    10 mM 0.7567 mL 3.7833 mL 7.5666 mL 18.9165 mL
    15 mM 0.5044 mL 2.5222 mL 5.0444 mL 12.6110 mL
    20 mM 0.3783 mL 1.8916 mL 3.7833 mL 9.4582 mL
    25 mM 0.3027 mL 1.5133 mL 3.0266 mL 7.5666 mL
    30 mM 0.2522 mL 1.2611 mL 2.5222 mL 6.3055 mL
    40 mM 0.1892 mL 0.9458 mL 1.8916 mL 4.7291 mL
    50 mM 0.1513 mL 0.7567 mL 1.5133 mL 3.7833 mL
    60 mM 0.1261 mL 0.6305 mL 1.2611 mL 3.1527 mL
    80 mM 0.0946 mL 0.4729 mL 0.9458 mL 2.3646 mL
    100 mM 0.0757 mL 0.3783 mL 0.7567 mL 1.8916 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    trans-Cinnamaldehyde
    Cat. No.:
    HY-W019711
    Quantity:
    MCE Japan Authorized Agent: